NDC 0597-0001

Aggrenox

Aspirin And Dipyridamole

Aggrenox is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Boehringer Ingelheim Pharmaceuticals, Inc.. The primary component is Aspirin; Dipyridamole.

• Product ID: 0597-0001_6edfba41-30e3-d958-b1dc-eb1b5ca9896b
• NDC: 0597-0001
• Product Type: Human Prescription Drug
• Proprietary Name: Aggrenox
• Generic Name: Aspirin And Dipyridamole
• Dosage Form: Capsule, Extended Release
• Route of Administration: ORAL
• Marketing Start Date: 1999-12-19
• Marketing Category: NDA / NDA
• Application Number: NDA020884
• Labeler Name: Boehringer Ingelheim Pharmaceuticals, Inc.
• Substance Name: ASPIRIN; DIPYRIDAMOLE
• Active Ingredient Strength: 25 mg/1; mg/1
• Pharm Classes: Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0597-0001-60

1 BOTTLE in 1 CARTON (0597-0001-60) > 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

• Marketing Start Date: 1999-12-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0597-0001-60 [00597000160]

Aggrenox CAPSULE, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA020884
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 1999-12-19

NDC 0597-0001-11 [00597000111]

Aggrenox CAPSULE, EXTENDED RELEASE

• Marketing Category: NDA
• Application Number: NDA020884
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1999-12-19
• Marketing End Date: 2017-03-01

Drug Details

Active Ingredients

Ingredient	Strength
ASPIRIN	25 mg/1

OpenFDA Data

• SPL SET ID: 938ab0b5-8377-404a-8f61-5c630bda5932
• Manufacturer:
  • Boehringer Ingelheim Pharmaceuticals, Inc.
• UNII:
  • R16CO5Y76E
  • 64ALC7F90C
• RxNorm Concept Unique ID - RxCUI:
  • 1362082
  • 259081
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

Pharmacological Class

• Cyclooxygenase Inhibitors [MoA]
• Decreased Prostaglandin Production [PE]
• Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
• Nonsteroidal Anti-inflammatory Drug [EPC]
• Platelet Aggregation Inhibitor [EPC]
• Decreased Platelet Aggregation [PE]
• Decreased Platelet Aggregation [PE]
• Platelet Aggregation Inhibitor [EPC]
• Anti-Inflammatory Agents
• Non-Steroidal [CS]

NDC Crossover Matching brand name "Aggrenox" or generic name "Aspirin And Dipyridamole"

NDC	Brand Name	Generic Name
0597-0001	Aggrenox	aspirin and dipyridamole
21695-656	Aggrenox	aspirin and dipyridamole
68151-3971	Aggrenox	aspirin and dipyridamole
0093-3040	Aspirin and Dipyridamole	Aspirin and Dipyridamole
0093-3064	Aspirin and Dipyridamole	Aspirin and Dipyridamole
0115-1711	aspirin and dipyridamole	aspirin and dipyridamole
0781-2141	aspirin and dipyridamole	aspirin and dipyridamole
16714-964	Aspirin and Dipyridamole	Aspirin and Dipyridamole
43598-339	Aspirin and Dipyridamole	Aspirin and Dipyridamole
70436-092	aspirin and dipyridamole	aspirin and dipyridamole